Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Vanda Pharmaceuticals (VNDA) Depreciation Expense (2017 - 2025)

Historic Depreciation Expense for Vanda Pharmaceuticals (VNDA) over the last 9 years, with Q4 2025 value amounting to $304000.0.

  • Vanda Pharmaceuticals' Depreciation Expense rose 1603.05% to $304000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 million, marking a year-over-year increase of 2255.56%. This contributed to the annual value of $1.1 million for FY2025, which is 2255.56% up from last year.
  • Vanda Pharmaceuticals' Depreciation Expense amounted to $304000.0 in Q4 2025, which was up 1603.05% from $301000.0 recorded in Q3 2025.
  • Vanda Pharmaceuticals' Depreciation Expense's 5-year high stood at $374000.0 during Q4 2021, with a 5-year trough of $200000.0 in Q3 2023.
  • For the 5-year period, Vanda Pharmaceuticals' Depreciation Expense averaged around $277000.0, with its median value being $287500.0 (2022).
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Depreciation Expense crashed by 3311.04% in 2023, and later surged by 3935.19% in 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Depreciation Expense (Quarter) stood at $374000.0 in 2021, then dropped by 24.06% to $284000.0 in 2022, then decreased by 27.82% to $205000.0 in 2023, then rose by 27.8% to $262000.0 in 2024, then increased by 16.03% to $304000.0 in 2025.
  • Its Depreciation Expense was $304000.0 in Q4 2025, compared to $301000.0 in Q3 2025 and $267000.0 in Q2 2025.